Eve review
A flat $195 a month for either compounded semaglutide or tirzepatide — plus a sublingual oral version at the same price — from a program built specifically around women's health, though the states you're eligible in and the pharmacy behind it aren't spelled out until you're inside the signup flow.
then $195/mo ongoing
- Independently scored
- Verified
Every medical claim in this piece is footnoted to the record it came from — the trial or the FDA label — so you can read the source rather than take the masthead's word for it. No one on this desk is your clinician.
Eve at a glance
- Semaglutide
- $195/mo
- Tirzepatide
- $195/mo
- Coverage
- Multiple states (not fully enumerated — confirm yours before signing up)
- Brand-name
- Yes
How we scored Eve
Each score comes out of Eve's published pricing, disclosures and oversight, and the six combine into the 70/100 Editors' Rating on the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
Fair value once you read past any teaser rate or plan structure.
Oversight and lab support fall short of the top of this roster — the review below says exactly where.
The headline rate obscures a plan requirement or a hidden step-up.
Little here is shaped around a mother's week or her life stage.
Support is thin once the prescription ships.
Cancellation is workable but not frictionless.
How we verified this review
- Last verified
- August 2026
- Confidence
- medium
- Primary source
- www.tryeve.co
$195 for either molecule — though the public page shows only a $0 and $99 promotional fragment, with standing pricing gated behind a signup funnel. Eve does not enumerate its states; it promises instead to follow you if you move somewhere it serves, which is not the same as telling you where that is.
What to expect when you sign up
We walked Eve's public signup funnel (August 2026) — a first-hand look at the flow. We don't create accounts, enter medical data, or complete checkout, so this is what any visitor sees, not a patient outcome.
- 1The signup call to action leaves tryeve.co for my.tryeve.co, a separate host
- 2The intake responded HTTP 200 when checked on 2026-08-21
- 3Walked to the intake entry only. No personal information was submitted, so nothing past the entry screen is asserted here
What we noticed
- The intake runs on Bask Health rather than on the provider's own software
- No monthly price is visible on the public homepage; the number appears only after you begin the intake
- Intake is hosted on my.tryeve.co, so the company you fill the form in with is not the domain you started on
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutide | $99 → $195 | All doses (flat)Promo code semfirst99 discounts the first month to $99; the standing price is $195/mo flat at every dose, and the same $195 flat rate covers either molecule on one account. |
| Compounded tirzepatide | $99 → $195 | All doses (flat)Same $195/mo flat rate and semfirst99 first-month promo as semaglutide. |
| Oral semaglutide | $195 | Sublingual (oral)A needle-free sublingual compounded semaglutide option, at the same $195/mo flat rate. |
| Brand semaglutide | $1399 | Ozempic® (brand-name) |
| Brand semaglutide | $1699 | Wegovy® (brand-name) |
| Brand tirzepatide | $1399 | Mounjaro® (brand-name) |
Swipe the table to see plan details →
GLP-1 telehealth is usually HSA- and FSA-eligible, so check your own plan. Everything above comes from Eve's public disclosures at last review and change often; confirm the current number on Eve's own site.
What we like
- One flat $195/mo price covers either compounded semaglutide or tirzepatide, plus a sublingual oral option at the same rate
- Brand-name Ozempic, Wegovy and Mounjaro are also available on the same platform for a reader who wants an FDA-approved pen
- "You pay $0 unless approved by a licensed physician" — no charge for a declined intake, per its own copy
- Free shipping on orders above $50, and a LegitScript-verified pharmacy relationship (ID 42862417)
The caveats
- Full standing pricing sits behind the go.tryeve.co signup flow — the public site only shows the $0/$99 promo fragment up front, not the $195 ongoing rate
- States aren't enumerated; the site only promises it will follow you if you move to a state it currently serves
- Pharmacy partner name, 503A/503B designation, medical director and corporate entity are not disclosed
- The $99 first-month price is a promo, not the real ongoing cost — budget for $195/mo after that
Eve for mothers: our verdict
A flat $195 a month for either compounded semaglutide or tirzepatide — plus a sublingual oral version at the same price — from a program built specifically around women's health, though the states you're eligible in and the pharmacy behind it aren't spelled out until you're inside the signup flow. The advertised entry is $99, but the standing rate settles near $195/month — so read the headline as a starting offer, not the real monthly cost.
We weigh Eve the way mothers actually have to: not just the real monthly cost, but the real monthly cost once the dose climbs and whether a real clinician stands behind it — the things a generic roundup never gets to.
What Eve actually costs
- Compounded semaglutide — All doses (flat): $99 to start, then $195/mo
- Compounded tirzepatide — All doses (flat): $99 to start, then $195/mo
- Oral semaglutide — Sublingual (oral): $195/mo
- Brand-name semaglutide — Ozempic® (brand-name): $1399/mo
- Brand-name semaglutide — Wegovy® (brand-name): $1699/mo
- Brand-name tirzepatide — Mounjaro® (brand-name): $1399/mo
That's roughly in line with the ~$179/month median across our roster.
The medications Eve prescribes
Eve prescribes semaglutide and tirzepatide — the pair with the strongest evidence behind them, and having both under one account matters when insulin resistance, familiar from PCOS and gestational diabetes, makes tirzepatide the better fit. It can also route you to FDA-approved brand pens rather than only compounded vials, and those carry the manufacturer's own pregnancy and lactation labeling, which is a cleaner document to take to an OB.
A needle-free oral or sublingual option is on the menu, which draws in mothers who've been avoiding injections — just set expectations: oral and buccal delivery of these peptides is far less studied than the injectable versions the trials used.
Where Eve fits — and where it doesn't — for mothers
Worth it if…
- you want a real clinician reading your history around the real monthly cost once the dose climbs, not an auto-approving quiz.
- you may need to move between semaglutide and tirzepatide as your body and hormones change.
Give it a miss if…
- you'd rather a prescriber talk through timing around the real monthly cost once the dose climbs — that's what our #1 pick, CoreAge Rx, is built for.
Trust, safety, and oversight
Our confidence is moderate — the core facts check out, but some details (per-state availability, program mechanics) aren't fully public. As with any compounded GLP-1, the most useful thing mothers can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our Editors' Rating methodology.
A standing caveat for mothers: GLP-1 medications aren't established as safe during pregnancy or breastfeeding, and every label advises against use. Nothing here changes that — plan the timing with your own clinician.
The bottom line
Eve is a reasonable option — weigh it on the real monthly cost once the dose climbs and whether a real clinician stands behind it against the alternatives below. For most mothers, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.
The bottom line for mothers
Best for: Mothers who want one flat price across both molecules and a genuine oral option, from a program explicitly positioned around women's health, and don't mind full pricing sitting behind the signup flow rather than the homepage.
Alternatives to Eve
Providers we have a referral relationship with, ordered by their Editors' Rating — highest first. A fee never moves a rating, but it does decide who appears here, so this is not the whole roster: the full ranking lists every provider we cover.
- Visit CoreAge RxCoreAge RxOur #1 pick
The one program on this masthead whose number still makes sense at the top of the dose. A flat, all-in monthly price on both molecules, no teaser rate to expire, and a cancel button you can actually find — the closest thing to a family-budget guarantee we've reviewed.
- Visit Gala Health
A flat $179 for either molecule and a genuinely gentle microdosing tier — a reasonable, all-doses-included option, if you can live with a yearly plan and a pharmacy the marketing never names.
- Visit Sesame
A high-trust telehealth marketplace that took a clear side: FDA-approved brand GLP-1 only, no compounded shortcut. You pay a brand cash price and book a real video visit — but you get on-label pens and one of the cleaner reputations on this masthead.
Keep comparing Eve
Head-to-head & alternatives
Eve, answered
- What does Eve really cost a month?
- The standing price is $195/month flat, whether you're on compounded semaglutide or compounded tirzepatide — the same account covers either, and a sublingual oral version of semaglutide runs at that same $195 rate. A promo code (semfirst99) knocks the first month to $99, but budget for $195 going forward; that first-month figure is the one Eve advertises loudest on its homepage.
- Can Eve prescribe brand-name Ozempic or Wegovy?
- Yes — Eve lists brand-name Ozempic and Mounjaro near $1,399/month and Wegovy near $1,699/month, alongside its compounded options. That's a real convenience if you want the manufacturer's own FDA pregnancy and lactation labeling to hand your OB, but it runs seven times the compounded rate, so the value here is optionality, not a bargain.
- Will Eve serve my state?
- Eve doesn't publish a state list — its copy only promises the program will "follow you if you relocate to a state we currently serve," which tells you states are excluded without saying which ones. Confirm your state during the go.tryeve.co signup flow before assuming you're covered.
- Is Eve legitimate?
- Eve displays a LegitScript seal (ID 42862417, verifiable directly at legitscript.com) and states plainly that compounded medications aren't FDA-reviewed for safety or effectiveness — the same disclaimer every compounding pharmacy is required to carry. What Eve doesn't disclose is its pharmacy partner's name, its 503A/503B designation, or a named medical director, so you're trusting the LegitScript badge more than a fully named chain of custody.
Pricing, states and verification reflect Eve's public disclosures at last review; the Editors' Rating is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.